专家笔谈

儿童常见侵袭性肺部真菌病免疫机制和临床特点

  • 秦涛 ,
  • 许红梅
展开
  • 重庆医科大学附属儿童医院感染科 国家儿童健康与疾病临床医学研究中心 儿童发育疾病研究教育部重点实验室 儿童感染免疫重庆市重点实验室(重庆 400014)

收稿日期: 2023-05-16

  网络出版日期: 2023-08-10

基金资助

重庆市首批公共卫生重点学科(专科)

Clinical manifestations and immune mechanism of invasive pulmonary mycosis in children

  • Tao QIN ,
  • Hongmei XU
Expand
  • Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing 400014, China

Received date: 2023-05-16

  Online published: 2023-08-10

摘要

侵袭性肺部真菌病是由真菌引起的支气管肺部感染,出现气道黏膜炎症和肺部炎症肉芽肿,严重者可能导致坏死性肺炎,甚至血行播散到其他脏器。其发生发展取决于外界真菌致病因素和患者免疫功能的相互作用。儿童患有原发免疫功能缺陷、血液恶性肿瘤、接受造血干细胞移植或高强度免疫抑制剂应用,长期侵入性置管或者重症感染等情况均可能造成对真菌易感。文章对儿童侵袭性肺部真菌病的免疫学发病机制、临床表现特点要素进行探讨,希望能为疾病的早期发现提供理论依据。

本文引用格式

秦涛 , 许红梅 . 儿童常见侵袭性肺部真菌病免疫机制和临床特点[J]. 临床儿科杂志, 2023 , 41(8) : 566 -570 . DOI: 10.12372/jcp.2023.23e0435

Abstract

Invasive pulmonary mycosis is a fungal infection of the bronchi and lungs, causing inflammation of the airway mucosa and pulmonary inflammatory granulomas. In severe cases, necrotizing pneumonia may occur, and even hematogenous dissemination to other organs. Its occurrence and development depend on the interaction between external fungal pathogenic factors and the patient's immune function. Children with primary immune dysfunction, hematological malignancies, receiving hematopoietic stem cell transplantation or high-intensity immunosuppressive therapy, long-term invasive catheterization, or severe infections may be susceptible to fungi. This article discusses the immunological pathogenesis and clinical characteristics of invasive pulmonary mycosis in children, hoping to provide theoretical basis for the early detection of the disease.

参考文献

[1] Reddy GKK, Padmavathi AR, Nancharaiah YV. Fungal infections: pathogenesis, antifungals and alternate treatment approaches[J]. Curr Res Microb Sci, 2022, 3: 100137.
[2] Page L, Wallstabe J, Lother J, et al. CcpA- and Shm2-pulsed myeloid dendritic cells induce T-cell activation and enhance the neutrophilic oxidative burst response to aspergillus fumigatus[J]. Front Immunol, 2021, 12: 659752.
[3] Mircescu MM, Lipuma L, van Rooijen N, et al. Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection[J]. J Infect Dis, 2009, 200(4): 647-656.
[4] Stappers MHT, Clark AE, Aimanianda V, et al. Recognition of DHN-melanin by a C-type lectin receptor is required for immunity to Aspergillus[J]. Nature, 2018, 555(7696): 382-386.
[5] Dietschmann A, Schruefer S, Westermann S, et al. Phosphatidylinositol 3-kinase (PI3K) orchestrates aspergillus fumigatus-induced eosinophil activation independently of canonical toll-like receptor (TLR)/C-type-lectin receptor (CLR) signaling[J]. mBio, 2022, 13(4): e0123922.
[6] Chignard M, Balloy V, Sallenave JM, et al. Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts[J]. Clin Immunol, 2007, 124(3): 238-243.
[7] Zhang W, He D, Wei Y, et al. Suppression of aspergillus fumigatus germination by neutrophils is enhanced by endothelial-derived CSF3 production[J]. Front Microbiol, 2022, 13: 837776.
[8] Taylor PR, Roy S, Leal SM Jr, et al. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2[J]. Nat Immunol, 2014, 15(2): 143-151.
[9] Rudman J, Evans RJ, Johnston SA. Are macrophages the heroes or villains during cryptococcosis?[J]. Fungal Genet Biol, 2019, 132: 103261.
[10] Zhang M, Sun D, Shi M. Dancing cheek to cheek: Cryptococcus neoformans and phagocytes[J]. Springerplus, 2015, 4: 410.
[11] Wang Y, Pawar S, Dutta O, et al. Macrophage mediated immunomodulation during cryptococcus pulmonary infection[J]. Front Cell Infect Microbiol, 2022, 12: 859049.
[12] Alshabani K, Haq A, Miyakawa R, et al. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature[J]. Expert Rev Respir Med, 2015, 9(1): 89-96.
[13] Crum-Cianflone NF. Invasive aspergillosis associated with severe influenza infections[J]. Open Forum Infect Dis, 2016, 3(3): ofw171.
[14] Tragiannidis A, Roilides E, Walsh TJ, et al. Invasive aspergillosis in children with acquired immunodeficiencies[J]. Clin Infect Dis, 2012, 54(2): 258-267.
[15] Page ID, Richardson MD, Denning DW. Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)[J]. J Infect, 2016, 72(2): 240-249.
[16] Wardlaw AJ, Rick EM, Pur Ozyigit L, et al. New perspectives in the diagnosis and management of allergic fungal airway disease[J]. J Asthma Allergy, 2021, 14: 557-573.
[17] Singh M, Chauhan A, Paul N, et al. Need to re-look cut-off of Aspergillus-specific IgE levels in children with ABPA[J]. Mycoses, 2019, 62(9): 761-764.
[18] Toma P, Bertaina A, Castagnola E, et al. Fungal infections of the lung in children[J]. Pediatr Radiol, 2016, 46(13): 1856-1865.
[19] Kassner EG, Kauffman SL, Yoon JJ, et al. Pulmonary candidiasis in infants: clinical, radiologic, and pathologic features[J]. AJR Am J Roentgenol, 1981, 137(4): 707-716.
[20] Huang J, Lan C, Li H, et al. Concomitant lung adenocarcinoma and pulmonary cryptococcosis confirmed by pathologic examinations[J]. Medicine, 2019, 98(50): e18316.
[21] Yao K, Qiu X, Hu H, et al. Pulmonary cryptococcosis coexisting with central type lung cancer in an immuoc-ompetent patient: a case report and literature review[J]. BMC Pulm Med, 2020, 20(1): 161.
[22] Tobon AM, Gomez BL. Pulmonary histoplasmosis[J]. Mycopathologia, 2021, 186(5): 697-705.
[23] Azar MM, Loyd JL, Relich RF, et al. Current concepts in the epidemiology, diagnosis, and management of histoplasmosis syndromes[J]. Semin Respir Crit Care Med, 2020, 41(1): 13-30.
[24] Fischer GB, Mocelin H, Severo CB, et al. Histoplasmosis in children[J]. Paediatr Respir Rev, 2009, 10(4): 172-177.
[25] Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis[J]. Clin Infect Dis, 2011, 53(5): 448-454.
[26] Jude CM, Nayak NB, Patel MK, et al. Pulmonary coccidioidomycosis: pictorial review of chest radiographic and CT findings[J]. Radiographics, 2014, 34(4): 912-925.
[27] Galgiani JN, Ampel NM, Blair JE, et al. Cocci-dioidomycosis[J]. Clin Infect Dis, 2005, 41(9): 1217-1223.
[28] Rego de Figueiredo I, Vieira Alves R, Drummond Borges D, et al. Pneumocystosis pneumonia: a comparison study between HIV and non-HIV immunocompromised patients[J]. Pulmonology, 2019, 25(5): 271-274.
文章导航

/